| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |